Published in Eur Heart J on February 02, 2011
ESC Guidelines on the management of cardiovascular diseases during pregnancy: the Task Force on the Management of Cardiovascular Diseases during Pregnancy of the European Society of Cardiology (ESC). Eur Heart J (2011) 5.11
Bivalirudin or Unfractionated Heparin in Acute Coronary Syndromes. N Engl J Med (2015) 4.68
A randomized multicenter study comparing a paclitaxel drug-eluting balloon with a paclitaxel-eluting stent in small coronary vessels: the BELLO (Balloon Elution and Late Loss Optimization) study. J Am Coll Cardiol (2012) 3.02
Routine assessment of on-clopidogrel platelet reactivity and gene polymorphisms in predicting clinical outcome following drug-eluting stent implantation in patients with stable coronary artery disease. JACC Cardiovasc Interv (2013) 2.11
Management of grown up congenital heart disease. Eur Heart J (2003) 1.94
First human case of esophagus-tracheal fistula closure by using a cardiac septal occluder (with video). Gastrointest Endosc (2010) 1.67
The first report of late stent thrombosis leading to acute myocardial infarction in patient receiving the new endothelial progenitor cell capture stent. Int J Cardiol (2009) 1.58
Rotational atherectomy in resistant chronic total occlusions. Catheter Cardiovasc Interv (2010) 1.47
Immunosuppressive therapy with oral prednisone to prevent restenosis after PCI. A multicenter randomized trial. Am J Med (2011) 1.42
Questions on the first consensus document of the ICCS-SPREAD Joint Committee on Carotid Artery Stenting. Stroke (2007) 1.39
In-stent restenosis in small coronary arteries: impact of strut thickness. J Am Coll Cardiol (2002) 1.30
First clinical experience with a paclitaxel derivate-eluting polymer stent system implantation for in-stent restenosis: immediate and long-term clinical and angiographic outcome. Circulation (2002) 1.14
Randomized evaluation of polytetrafluoroethylene-covered stent in saphenous vein grafts: the Randomized Evaluation of polytetrafluoroethylene COVERed stent in Saphenous vein grafts (RECOVERS) Trial. Circulation (2003) 1.04
Platypnoea-orthodeoxia syndrome secondary to patent foramen ovale (PFO): a challenging subset for PFO percutaneous closure. Heart Lung Circ (2013) 1.00
Iatrogenic aortic dissection during coronary intervention. Ital Heart J (2003) 1.00
A prospective, randomized trial of intravascular-ultrasound guided compared to angiography guided stent implantation in complex coronary lesions: the AVIO trial. Am Heart J (2012) 0.97
New echocardiographic diameter for Amplatzer sizing in adult patients with secundum atrial septal defect: preliminary results. Catheter Cardiovasc Interv (2004) 0.92
Influence of pentraxin 3 (PTX3) genetic variants on myocardial infarction risk and PTX3 plasma levels. PLoS One (2012) 0.91
Assessment of the 9p21.3 locus in severity of coronary artery disease in the presence and absence of type 2 diabetes. BMC Med Genet (2013) 0.90
Current applications of optical coherence tomography for coronary intervention. Int J Cardiol (2012) 0.89
Transcatheter valve-in-valve implantation using Corevalve Revalving System for failed surgical aortic bioprostheses. JACC Cardiovasc Interv (2011) 0.88
Anomalous origin of the left coronary artery from the pulmonary artery in an adult pregnant patient: surgical and percutaneous myocardial revascularization. Ital Heart J (2005) 0.87
Percutaneous coronary intervention versus bypass surgery for left main coronary artery disease: a meta-analysis of randomised trials. EuroIntervention (2011) 0.85
Effectiveness and safety of sirolimus-eluting stents in the treatment of restenosis after coronary stent placement. Circulation (2005) 0.84
Very late multivessel thrombosis of bare metal stents with concomitant patent drug-eluting stents after withdrawal of aspirin. Int J Cardiol (2007) 0.84
Images in cardiovascular medicine. Intra-arterial thrombolysis for left middle cerebral artery embolic stroke during coronary angiography. Circulation (2006) 0.83
Inaccuracy of available surgical risk scores to predict outcomes after transcatheter aortic valve replacement. J Cardiovasc Med (Hagerstown) (2013) 0.83
Percutaneous treatment of severe retrograde dissection of the circumflex artery involving left main stem and extending into the sinus of Valsalva. Int J Cardiol (2007) 0.83
CoreValve implantation for severe aortic regurgitation: a multicentre registry. EuroIntervention (2014) 0.83
Simplifying clinical risk prediction for percutaneous coronary intervention of bifurcation lesions: the case for the ACEF (age, creatinine, ejection fraction) score. EuroIntervention (2012) 0.81
Gender-based issues in interventional cardiology: a consensus statement from the Women in Innovations (WIN) Initiative. Catheter Cardiovasc Interv (2010) 0.81
Gender-based issues in interventional cardiology: a consensus statement from the Women in Innovations (WIN) initiative. EuroIntervention (2010) 0.81
Elective versus provisional intra-aortic balloon pumping in high-risk percutaneous transluminal coronary angioplasty. Am Heart J (2003) 0.81
Early and long-term outlook of percutaneous coronary intervention for bifurcation lesions in young patients. Int J Cardiol (2012) 0.81
Is intravascular ultrasound beneficial for percutaneous coronary intervention of bifurcation lesions? Evidence from a 4,314-patient registry. Clin Res Cardiol (2011) 0.80
The EUROpean and Chinese cardiac and renal Remote Ischemic Preconditioning Study (EURO-CRIPS): study design and methods. J Cardiovasc Med (Hagerstown) (2015) 0.80
Resolute Italian study in all comers: immediate and one-year outcomes. Catheter Cardiovasc Interv (2011) 0.80
Impact of female sex on long-term outcomes in patients with ST-elevation myocardial infarction treated by primary percutaneous coronary intervention. Can J Cardiol (2011) 0.80
Closure of patent foramen ovale: when and how? Curr Vasc Pharmacol (2007) 0.79
Impact on prognosis of periprocedural bleeding after TAVI: mid-term follow-up of a multicenter prospective study. J Interv Cardiol (2014) 0.78
"Gender paradox" in outcome after percutaneous coronary intervention with paclitaxel eluting stents. EuroIntervention (2008) 0.78
The occupational effects of interventional cardiology: results from the WIN for Safety survey. EuroIntervention (2012) 0.78
Patterns and trends of transcatheter aortic valve implantation in Italy: insights from RISPEVA. J Cardiovasc Med (Hagerstown) (2016) 0.78
Left internal mammary artery to pulmonary artery fistula after minimally invasive coronary bypass. Ann Thorac Surg (2002) 0.77
Immediate and late results of coronary angioplasty in patients with severe left ventricular dysfunction. Ital Heart J (2003) 0.77
Evidence for a "gender paradox" in diabetic patients undergoing percutaneous coronary intervention: adverse preprocedural risk but favorable long-term clinical outcome in women. Ital Heart J (2005) 0.77
17-beta-estradiol eluting stent versus phosphorylcholine-coated stent for the treatment of native coronary artery disease. Am J Cardiol (2005) 0.77
3-Year Follow-Up of the Balloon Elution and Late Loss Optimization Study (BELLO). JACC Cardiovasc Interv (2015) 0.76
Transcatheter closure of secundum atrial septal defects with the Amplatzer occluder in adult patients. Ital Heart J (2002) 0.75
Rosiglitazone plus metformin to prevent type 2 diabetes mellitus. Lancet (2010) 0.75
A multicentre approach for the management of adults with congenital heart disease. J Cardiovasc Med (Hagerstown) (2006) 0.75
The gender paradox. EuroIntervention (2009) 0.75
Reply: Platelet reactivity is preferred over genotyping in monitoring efficacy of antiplatelet therapy. JACC Cardiovasc Interv (2014) 0.75
[Successful double retrograde approach for recanalization of double total chronic occlusions]. G Ital Cardiol (Rome) (2015) 0.75
Transcatheter aortic valve implantation in low ejection fraction/low transvalvular gradient patients: the rule of 40. J Cardiovasc Med (Hagerstown) (2017) 0.75
Tornus catheter and rotational atherectomy in resistant chronic total occlusions. Int J Cardiol (2012) 0.75
Intracoronary beta-radiation for the treatment of patients at very high risk for recurrence of in-stent restenosis: a single center experience. Ital Heart J (2003) 0.75
A multicenter, randomized study to test immunosuppressive therapy with oral prednisone for the prevention of restenosis after percutaneous coronary interventions: cortisone plus BMS or DES versus BMS alone to eliminate restenosis (CEREA-DES) - study design and rationale. J Cardiovasc Med (Hagerstown) (2009) 0.75
Elective stenting in small coronary arteries: results of the Italian prospective multicenter registry MICROSCOPE. Ital Heart J (2002) 0.75
Pulmonary embolism: diagnosis and follow-up by multislice computed tomography. Ital Heart J (2004) 0.75
Comparison between drug-eluting stents and beta-radiation for the treatment of diffuse in-stent restenosis: clinical and angiographic outcomes. Am Heart J (2006) 0.75
Confined late stent thrombosis following clopidogrel withdrawal in a patient with multi-segment sirolimus-eluting stent implants. J Cardiovasc Med (Hagerstown) (2007) 0.75
Sex differences in postprocedural aortic regurgitation and mid-term mortality after transcatheter aortic valve implantation. Catheter Cardiovasc Interv (2014) 0.75
Successful treatment by transcatheter aortic valve implantation of severe aortic regurgitation in a patient with ascending aorta prosthesis. Heart Lung Circ (2012) 0.75
How should I treat a DES restenosis in a graft anastomosis with challenging access and multiple previous coronary interventions? EuroIntervention (2016) 0.75
Motivations for and barriers to choosing an interventional cardiology career path: results from the EAPCI Women Committee worldwide survey. EuroIntervention (2016) 0.75
Poor outcome in patients treated with brachytherapy for diffuse in-stent restenosis. The role of additional stenting despite prolonged antiplatelet therapy. J Invasive Cardiol (2005) 0.75
Drug-eluting stents for the percutaneous treatment of the anastomosis of the left internal mammary graft to left anterior descending artery. Coron Artery Dis (2007) 0.75
Immediate removal of femoral-sheath following protamine administration in patients undergoing intracoronary paclitaxel-eluting-stent implantation. Expert Opin Pharmacother (2007) 0.75
In-hospital and midterm clinical outcomes of rotational atherectomy followed by stent implantation: the ROTATE multicentre registry. EuroIntervention (2016) 0.75
Is conventional antiplatelet therapy for the prevention of coronary stent thrombosis always safe? A case report of a patient with polycythemia vera. Ital Heart J (2004) 0.75
[Not Available]. Turk Kardiyol Dern Ars (2012) 0.75
Eisenmenger syndrome complicated by pulmonary artery dissection. Eur Heart J (2006) 0.75
"Do least harm" philosophy may suffice for percutaneous coronary intervention in octogenarians. J Interv Cardiol (2006) 0.75
Unusual case of paradoxical multisite embolization in a patient with patent foramen ovale. Int J Cardiol (2007) 0.75
Drug-eluting stent use after coronary atherectomy: results from a multicentre experience - The ROTALINK I study. J Cardiovasc Med (Hagerstown) (2016) 0.75
Prevalence of inherited thrombophilia in patients with documented stent thrombosis. Circ J (2012) 0.75
A thirty-four-year-old chronic total occlusion successfully treated by percutaneous coronary intervention. Int J Cardiol (2013) 0.75
Incidence, predictors, and impact on prognosis of systolic pulmonary artery pressure and its improvement after transcatheter aortic valve implantation: a multicenter registry. J Invasive Cardiol (2015) 0.75
Inflammatory substrate with eosinophils may be present in bare-metal stent thrombosis. J Cardiovasc Med (Hagerstown) (2009) 0.75
Endovascular treatment of traumatic bilateral internal carotid artery dissection. J Invasive Cardiol (2009) 0.75
Arteriovenous fistula complicating directional atherectomy of the popliteal artery. J Cardiovasc Med (Hagerstown) (2009) 0.75
Clinical outcomes of bioresorbable versus durable polymer-coated everolimus-eluting stents in real-world complex patients. EuroIntervention (2017) 0.75
Gender-based issues in interventional cardiology: a consensus statement from the Women in Innovations (WIN) initiative. Rev Esp Cardiol (2010) 0.75